Royalty Pharma up on $1 bln share-repurchase program

Royalty Pharma

27/03/2023 13:57

** Royalty Pharma  RPRX.O  rises 4.2% to $36.9 before the
bell
    ** Says it has authorized the repurchase of $1 billion worth
of company's shares
    ** The repurchase program is valid through 2027
    ** RPRX CEO and founder Pablo Legorreta additionally 
intends to purchase $50 million worth of co shares 
    ** Shares of RPRX down ~10% YTD

 (Reporting by Khushi Mandowara in Bengaluru)
 ((Khushi.Mandowara@thomsonreuters.com;))